#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous calcification Obliterative bronchiolitis Blood iron increased Carcinoid syndrome Autologous haematopoietic stem cell transplant Progressive supranuclear palsy Kawasaki's disease Complex regional pain syndrome Eosinophilic oesophagitis Epidermolysis bullosa Chemical burn Fibrodysplasia ossificans progressiva Immunodeficiency congenital Epileptic encephalopathy Waldenstrom's macroglobulinaemia refractory More trials…

    Learn about Rare Diseases

    Adrenocortical carcinoma – Basic Information Familial haemophagocytic lymphohistiocytosis – Trials in Disease Angiosarcoma – Basic Information Angiosarcoma – Trials in Disease Mantle cell lymphoma – Treatment Hereditary neuropathic amyloidosis Andersen-Tawil syndrome – Diagnostics Propionic acidaemia – Diagnostics Krabbe’s disease – Diagnostics Gastrointestinal stromal tumour More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Remdesivir Hydrocortisone Vinorelbine Tartrate Abiraterone Acetate Sodium Citrate Amiloride Loperamide Hydrochloride Memantine Hydrochloride Cldn6 Car-T(A) CHOLINE ALFOSCERATE GRNA-001 BW-20805 Hct116-A Daxdilimab Pantoprazole Ademetionine Irinotecan Indapamide Hydroxocobalamin WEF-001 More therapies…

    Learn about Your Condition

    Systemic scleroderma Aortic valve stenosis Foot deformity Iron deficiency anaemia Glaucoma Caesarean section Chronic lymphocytic leukaemia Ebola disease Hypervolaemia Metastasis Pigmentary glaucoma Gaucher's disease type III Barrett's oesophagus Carcinoid tumour pulmonary Palmoplantar pustulosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study on Early vs. Late Epoetin Alfa Treatment for Adults with Low-Risk MDS and Anemia Not Requiring Blood Transfusions

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Epoetin Alfa
    France

  • Study on the Effectiveness and Safety of Golcadomide and Rituximab for Patients with Newly Diagnosed Advanced Follicular Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Follicular lymphoma stage II
    • Follicular lymphoma stage III
    • Follicular lymphoma stage IV
    Investigated Drugs:
    • Bendamustine Hydrochloride
    • Betamethasone Sodium Phosphate
    • Cyclophosphamide
    France Germany Italy Poland Spain

  • Study on the Safety and Effectiveness of Azacitidine and Venetoclax for Patients with Higher-Risk Chronic Myelomonocytic Leukemia (CMML)

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Azacitidine
    • Venetoclax
    France

  • Study of dose reduction strategy for tyrosine kinase inhibitors (imatinib, ponatinib, bosutinib, nilotinib, dasatinib) in patients with chronic myeloid leukemia

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Imatinib Mesilate
    • Ponatinib
    • Bosutinib
    The Netherlands

  • Study of decitabine and cedazuridine combination in patients with lower-risk myelodysplastic syndromes

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Cedazuridine
    • Decitabine
    Belgium Germany Spain

  • Study on Isatuximab and CellProtect for Maintenance Treatment in Patients with Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplant

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Evencaleucel
    • Isatuximab
    Sweden
Previous Page
1 … 58 59 60 61 62 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!